Meritxell Alberich-Jorda
Overview
Explore the profile of Meritxell Alberich-Jorda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1086
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhao X, Bartholdy B, Yamamoto Y, Evans E, Alberich-Jorda M, Staber P, et al.
Commun Biol
. 2022 Sep;
5(1):961.
PMID: 36104445
The Ets transcription factor PU.1 is essential for inducing the differentiation of monocytes, macrophages, and B cells in fetal liver and adult bone marrow. PU.1 controls hematopoietic differentiation through physical...
12.
Lobo de Figueiredo-Pontes L, Adamcova M, Welner R, Tenen D, Alberich-Jorda M
Stem Cell Reports
. 2022 Mar;
17(3):446-447.
PMID: 35263572
No abstract available.
13.
Stavast C, van Zuijen I, Karkoulia E, Ozcelik A, van Hoven-Beijen A, Leon L, et al.
Leukemia
. 2021 Nov;
36(3):687-700.
PMID: 34741119
MIR139 is a tumor suppressor and is commonly silenced in acute myeloid leukemia (AML). However, the tumor-suppressing activities of miR-139 and molecular mechanisms of MIR139-silencing remain largely unknown. Here, we...
14.
Lobo de Figueiredo-Pontes L, Adamcova M, Grusanovic S, Kuzmina M, Aparecida Lopes I, Fernandes de Oliveira Costa A, et al.
Stem Cell Reports
. 2021 Jul;
16(8):1999-2013.
PMID: 34242616
Hematopoietic stem cell transplantation (HSCT) is a frequent therapeutic approach to restore hematopoiesis in patients with hematologic diseases. Patients receive a hematopoietic stem cell (HSC)-enriched donor cell infusion also containing...
15.
Danek P, Kardosova M, Janeckova L, Karkoulia E, Vanickova K, Fabisik M, et al.
Blood
. 2020 Aug;
136(22):2574-2587.
PMID: 32822472
The canonical Wnt signaling pathway is mediated by interaction of β-catenin with the T-cell factor/lymphoid enhancer-binding factor (TCF/LEF) transcription factors and subsequent transcription activation of Wnt-target genes. In the hematopoietic...
16.
Lukes Jr J, Danek P, Alejo-Valle O, Potuckova E, Gahura O, Heckl D, et al.
Leukemia
. 2020 Feb;
34(9):2503-2508.
PMID: 32094462
No abstract available.
17.
Qi Y, Fang Y, Sinclair D, Guo S, Alberich-Jorda M, Lu J, et al.
PLoS One
. 2020 Feb;
15(2):e0228651.
PMID: 32045462
A new computational framework for FLow cytometric Analysis of Rare Events (FLARE) has been developed specifically for fast and automatic identification of rare cell populations in very large samples generated...
18.
Borna S, Drobek A, Kralova J, Glatzova D, Splichalova I, Fabisik M, et al.
J Cell Mol Med
. 2019 Dec;
24(2):1980-1992.
PMID: 31845480
WW domain binding protein 1-like (WBP1L), also known as outcome predictor of acute leukaemia 1 (OPAL1), is a transmembrane adaptor protein, expression of which correlates with ETV6-RUNX1 (t(12;21)(p13;q22)) translocation and...
19.
Balounova J, Splichalova I, Dobesova M, Kolar M, Fiser K, Prochazka J, et al.
Nat Commun
. 2019 Nov;
10(1):5176.
PMID: 31729371
Hematopoiesis in mammalian embryos proceeds through three successive waves of hematopoietic progenitors. Since their emergence spatially and temporally overlap and phenotypic markers are often shared, the specifics regarding their origin,...
20.
Hartmann J, Brauer-Hartmann D, Kardosova M, Wurm A, Wilke F, Schodel C, et al.
Cell Death Dis
. 2018 Jul;
9(8):814.
PMID: 30050105
Hematopoiesis, the formation of blood cells from hematopoietic stem cells (HSC), is a highly regulated process. Since the discovery of microRNAs (miRNAs), several studies have shown their significant role in...